|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.96 USD | -3.26% |
|
-0.18% | +0.30% |
| 01-14 | Truist Securities Adjusts Price Target on Exelixis to $51 From $49, Maintains Buy Rating | MT |
| 01-13 | Exelixis, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 05:15 PM |
| Capitalization | 11.83B 10.2B 9.5B 8.84B 16.46B 1,074B 17.71B 109B 43.08B 512B 44.38B 43.47B 1,870B | P/E ratio 2025 * |
16.8x | P/E ratio 2026 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise value | 11.25B 9.7B 9.03B 8.41B 15.66B 1,021B 16.84B 104B 40.97B 487B 42.21B 41.34B 1,779B | EV / Sales 2025 * |
4.84x | EV / Sales 2026 * | 4.13x |
| Free-Float |
98.21% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Exelixis, Inc.
| 1 day | -3.26% | ||
| 1 week | -0.18% | ||
| Current month | +0.30% | ||
| 1 month | +4.67% | ||
| 3 months | +12.00% | ||
| 6 months | -2.03% | ||
| Current year | +0.30% |
| 1 week | 42.05 |  | 45.77 |
| 1 month | 41.93 | | 47.24 |
| Current year | 41.93 | | 46.31 |
| 1 year | 31.9 | | 49.62 |
| 3 years | 16.14 | | 49.62 |
| 5 years | 14.87 | | 49.62 |
| 10 years | 3.55 | | 49.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 22/07/2010 | |
| Director of Finance/CFO | 58 | 15/07/2015 | |
Dana Aftab
COO | Chief Operating Officer | 63 | 01/02/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 01/02/2004 | |
George Poste
BRD | Director/Board Member | 82 | 01/08/2004 |
| Chairman | 77 | 01/01/1998 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -4.10% | 13.24% | 303 M€ | |
| 0.00% | 2.62% | 1 M€ | |
| 0.00% | 1.67% | 5 M€ | |
| 0.00% | 1.59% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.26% | -0.18% | +21.44% | +169.36% | 11.83B | |
| -0.49% | 0.00% | +8.75% | +88.27% | 49.24B | |
| +0.71% | +5.27% | +96.79% | +9.03% | 44.64B | |
| +1.35% | -8.27% | +122.62% | +744.25% | 34.43B | |
| +2.76% | +9.16% | -2.62% | -23.88% | 27.35B | |
| -0.60% | +7.34% | +121.49% | -42.68% | 21.08B | |
| +0.97% | +0.14% | +44.75% | -20.98% | 20.89B | |
| -0.74% | -5.17% | +104.56% | +168.59% | 14.29B | |
| +0.72% | -0.55% | +191.39% | - | 14.17B | |
| -1.33% | -13.41% | -10.46% | +271.24% | 13.14B | |
| Average | +0.01% | -0.52% | +69.87% | +151.47% | 25.11B | |
| Weighted average by Cap. | +0.32% | +0.47% | +66.59% | +153.48% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.33B 2.01B 1.87B 1.74B 3.24B 211B 3.48B 21.49B 8.47B 101B 8.73B 8.55B 368B | 2.6B 2.24B 2.08B 1.94B 3.61B 236B 3.89B 23.97B 9.45B 112B 9.74B 9.54B 410B |
| Net income | 734M 633M 589M 548M 1.02B 66.6B 1.1B 6.78B 2.67B 31.77B 2.75B 2.7B 116B | 822M 708M 660M 614M 1.14B 74.57B 1.23B 7.59B 2.99B 35.57B 3.08B 3.02B 130B |
| Net Debt | -580M -500M -465M -433M -806M -52.58B -867M -5.35B -2.11B -25.08B -2.17B -2.13B -91.58B | -1.1B -952M -886M -825M -1.54B -100B -1.65B -10.2B -4.02B -47.8B -4.14B -4.06B -175B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 43.96 $ | -3.26% | 2,898,708 |
| 15/01/26 | 45.44 $ | +0.46% | 2,268,764 |
| 14/01/26 | 45.23 $ | +2.61% | 1,722,698 |
| 13/01/26 | 44.08 $ | +0.05% | 2,082,466 |
| 12/01/26 | 44.06 $ | +0.05% | 4,143,134 |
Delayed Quote Nasdaq, January 17, 2026 at 05:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EXEL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition